RE:RE:Health Clinics Limited .. (target company)Bottom line, the US arm matches the UK arm: Micro size, distressed and with lots of 'visions' (so to speak).
Almost no employees in the UK or US and indebted, not profitable,
just $34,741 annual revs for the US branch in 2021 (see DNB link).
The parent even filed an FDA trial about to start for their COC cocktails,
also see the inspire reviews/discussions.
The trial will be costly as well, hello SZLS SH.
IMHO really not worth 23M shares, not at all.
But then, SZLS also has no 3rd party validated cancer test (trial, FDA certificate),
just the lab cert.
For me (my sole opinion), this 'asset purchase' is another interesting path
to create some sort of new story line here and keeping them afloat.
Why? They probably got rejected by the insurance company for the planned
employer test plans.